A team of researchers at The University of Texas MD Anderson Cancer Center has developed a new method for using extracellular vesicles to enhance responses to immunotherapy in glioblastoma, potentially opening the door for wider use of engineered messenger RNA (mRNA) for cancer therapy. The study was published today in Nature Communications.
Click here for original story, mRNA delivered by extracellular vesicles induces immunotherapy response in glioblastoma
Source: Phys.org